Liwei Bao
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- RNA Interference and Gene Delivery 2
- Oncology 13
- Cancer Cells and Metastasis 11
- Cancer-related Molecular Pathways 2
- Co-authors
- Sofía D. Merajver (25 shared papers)Zhifen Wu (9 shared papers)Steven G. Allen (4 shared papers)Weiqiang Chen (3 shared papers)Jianping Fu (3 shared papers)Raymond H. W. Lam (2 shared papers)Jill A. Macoska (1 shared paper)Feng Zhang (1 shared paper)
- Journals
- Cancer Research (7 papers)Frontiers in Oncology (2 papers)Scientific Reports (2 papers)Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesChinaHong Kong
In The Last Decade
Liwei Bao
29 papers receiving 857 citations
Peers
Comparison fields: 5 of 83
- Oncology 339
- Cancer Research 134
- Immunology and Allergy 53
- Molecular Biology 398
- Cell Biology 88
Countries citing papers authored by Liwei Bao
This map shows the geographic impact of Liwei Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Bao more than expected).
Fields of papers citing papers by Liwei Bao
This network shows the impact of papers produced by Liwei Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Bao. The network helps show where Liwei Bao may publish in the future.
Co-authors
The 25 scholars most cited alongside Liwei Bao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 206 | |
| 2 | A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells. | 1999 | 96 |
| 3 | 2019 | 87 | |
| 4 | 2002 | 66 | |
| 5 | 2012 | 58 | |
| 6 | 2011 | 49 | |
| 7 | 2016 | 42 | |
| 8 | 2018 | 31 | |
| 9 | 2009 | 28 | |
| 10 | 2016 | 27 | |
| 11 | 2019 | 23 | |
| 12 | 2016 | 23 | |
| 13 | 2024 | 21 | |
| 14 | 2020 | 20 | |
| 15 | 2009 | 19 | |
| 16 | 2018 | 13 | |
| 17 | 2021 | 13 | |
| 18 | 2023 | 10 | |
| 19 | 2019 | 9 | |
| 20 | 2013 | 7 |
About Liwei Bao
Liwei Bao is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 31 papers that have together received 867 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (11 papers), Cancer Genomics and Diagnostics (5 papers), Immune cells in cancer (3 papers), Cellular Mechanics and Interactions (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Ferroptosis and cancer prognosis (2 papers), RNA Interference and Gene Delivery (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Oncology (339 citations), Cancer Research (134 citations), Immunology and Allergy (53 citations), Molecular Biology (398 citations) and Cell Biology (88 citations). Liwei Bao has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Sofía D. Merajver, Zhifen Wu, Steven G. Allen, Weiqiang Chen, Jianping Fu, Raymond H. W. Lam, Jill A. Macoska, Feng Zhang, Shinuo Weng and Joel A. Yates. Their work appears in journals such as Cancer Research, Frontiers in Oncology, Scientific Reports, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.